The use of intravenous contrast media in computerized tomography (CT) is of paramount importance to improve diagnostic accuracy. In radiological diagnostics, many times, the difference between certain organs or tissues may not be evident. For such cases, the utilization of contrast agents highlights body cavities to be distinguished from each other.
Browse Full Market Research Report on Contrast Media Injectors Market: http://www.transparencymarketresearch.com/contrast-media-injectors.html
With the manifestation of ever-increasing technological sophistication in healthcare from manifold manual injectors to stop-cocks to automated types, contrast injectors have evolved phenomenally for higher precision. These automated contrast media injectors are known as autoinjectors and offer a range of benefits, such as lower quantity of contrast media required to be injected, and also can monitor the patient if the dosage needs to be increased to keep pace with advanced medical imaging scanners.
Trends in Contrast Media Injection Systems Market
Over the past few years, the use of dual-head injectors over single-head ones, integration of electronic medical record (EMR) systems, and features for improved patient safety have come to the fore among the trends impacting the automated contrast media injection systems market.
In the past decade, as a standard industry switch, single-head injectors developed in the 1970s have been replaced by dual-head injectors. The use of dual-syringe injectors has the advantage of reduced use of the contrast medium – alternate flow of saline and contrast media from the first and second head, respectively, into the veins helps reduce cost considerably.
Additionally, according to the experience of users, contrast media delivery, if administered through a dual-head injector, is much more efficient and controlled. These devices are also equipped to synchronize with the extremely quick imaging times offered by new multi-detector scanners for computed tomography.
Contrast Media Injectors (CMI) Market – A Snapshot
Worldwide, with increasing incidence of several life-threatening conditions, there has been a persistent rise in demand for imaging diagnostics such as CT and MRI. This in turn is driving demand for efficient contrast media injectors.
Furthermore, increasing awareness about early diagnosis of disorders has also led to increased usage of imaging procedures, thus fueling the contrast media injectors market.
For such reasons, research carried out by Transparency Market Research (TMR) projects the global contrast media injectors market to be valued at US$886.7 million by 2020, increasing from US$630.1 million in 2013 at a 5.0% CAGR from 2014 to 2020.
Presently, widespread deployment of CT machines due to their multitude of advantages, such as low cost and greater patient compliance, over positron emission tomography (PET) and MRI is boosting demand for CT injectors. Thus, CT injectors are the fastest growing injector type in the overall contrast media injectors market.
CMI-induced imaging enables bolus chasing and control of media flow, thus resulting in significant improvement in radiographic images. Contrast-enhanced imaging is mostly used for neurological. gastrointestinal, oncological, and musculoskeletal diseases.
Browse Press Release on Contrast Media Injectors Market: http://www.transparencymarketresearch.com/pressrelease/contrast-media-injectors-market.htm
In the present scenario, MRI and CT imaging procedures find extensive application in neurological conditions. Neuroimaging (CT, PET, MRI, and others) carried out with contrast media are optimally suited to detecting brain injuries, tumor, intracranial hemorrhages, and acute neurological changes.
According to a study published in NeuroRX on brain injury, approximately 1.6 million head injuries are reported in the U.S every year, with 48% (moderate to severe) of these injuries requiring medical imaging. Hence, North America accounts for a major chunk of revenue in the contrast media injectors market.